Paula Soteropoulos sold $2.2M of Dianthus Therapeutics (DNTH)

Executed Mar 24, disclosed Mar 26, 2 days later.

Value, as filed

$2.2M

27,594 sh × $78.05

Executed

Mar 24

the trade date, as filed

Disclosed

Mar 26

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Paula Soteropoulos Director profile →

Paula Soteropoulos (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $2.2M of DNTH (27,594 sh × $78.05, as filed), executed Mar 24.

The name

DNTH

Dianthus Therapeutics, Inc. DNTH · Healthcare · 18 filings in 24 months ticker →

Healthcare · Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→